Nothing Special   »   [go: up one dir, main page]

Yang et al., 2022 - Google Patents

Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer

Yang et al., 2022

View HTML @Full View
Document ID
9636039852934313368
Author
Yang Z
Dam K
Bridges M
Hoffmann M
DeLaitsch A
Gristick H
Escolano A
Gautam R
Martin M
Nussenzweig M
Hubbell W
Bjorkman P
Publication year
Publication venue
Nature communications

External Links

Snippet

Broadly-neutralizing antibodies (bNAbs) against HIV-1 Env can protect from infection. We characterize Ab1303 and Ab1573, heterologously-neutralizing CD4-binding site (CD4bs) antibodies, isolated from sequentially-immunized macaques. Ab1303/Ab1573 binding is …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus

Similar Documents

Publication Publication Date Title
Wang et al. Partially open HIV-1 envelope structures exhibit conformational changes relevant for coreceptor binding and fusion
Yang et al. Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer
Juraszek et al. Stabilizing the closed SARS-CoV-2 spike trimer
Kulp et al. Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding
Kong et al. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
He et al. HIV-1 vaccine design through minimizing envelope metastability
Van Gils et al. An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
Julien et al. Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans
Liu et al. Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer
Pancera et al. Structure and immune recognition of trimeric pre-fusion HIV-1 Env
Scharf et al. Broadly neutralizing antibody 8ANC195 recognizes closed and open states of HIV-1 Env
Sarkar et al. Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer
Wu et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing
Ying et al. Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
Pancera et al. Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1
Cormier et al. Cryo-EM structure of the αvβ8 integrin reveals a mechanism for stabilizing integrin extension
Yang et al. Asymmetric opening of HIV-1 Env bound to CD4 and a coreceptor-mimicking antibody
Shiakolas et al. Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking
Barnes et al. Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies
Gray et al. Unravelling the molecular basis of high affinity nanobodies against HIV p24: in vitro functional, structural, and in silico insights
Jette et al. Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation
Fera et al. HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope
Kumar et al. Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide
Wibmer et al. Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions
Yuan et al. Structural basis of a public antibody response to SARS-CoV-2